NYSE ARCA | ETF
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index.
The index seeks to track the performance of the common stock ofU. S. exchange-listed biotechnology companies with at least one drug therapy approved by theU. S.
Food and Drug Administration (FDA) for marketing.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals LLC | Healthcare | Drug Manufacturers - Specialty & Generic | 3.02% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 2.62% |
| ARDX | Ardelyx Inc | Healthcare | Biotechnology | 2.62% |
| RYTM | Rhythm Pharmaceuticals Inc | Healthcare | Biotechnology | 2.57% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 2.50% |
| AUP | Aurinia Pharmaceuticals Inc | Technology | Technical & System Software | 2.43% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 2.34% |
| APLS | Apellis Pharmaceuticals Inc | Healthcare | Biotechnology | 2.31% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 2.24% |
| NVAX | Novavax Inc | Healthcare | Biotechnology | 2.22% |
| MIRM | Mirum Pharmaceuticals Inc | Healthcare | Biotechnology | 2.21% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 2.18% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 2.18% |
| TARS | Tarsus Pharmaceuticals Inc | Healthcare | Biotechnology | 2.18% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 2.14% |
| MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 2.12% |
| TBPH | Theravance Biopharma Inc | Healthcare | Biotechnology | 2.11% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 2.05% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 2.05% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 2.04% |